ArticleHeart rhythm O22026
Contemporary practice about cardiac implantable electronic device infections prevention: A French multicenter survey.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac implantable electronic device infections remain a major complication. Preventive measures include antiseptic skin preparation, systemic antibiotic prophylaxis, and more recently the use of the absorbable TYRX antibiotic-eluting envelope (AEE). Despite explicit international recommendations, real-world adherence to guidelines is insufficiently documented. Objective: This study aimed to assess infection prevention practices across French hospital centers, with a particular focus on the recent European Society of Cardiology recommendations regarding AEE use. Methods: Data were collected from 33 French centers (51.3% private, 21.2% academic, 27.3% general hospitals). Each practitioner reported data for 5 patients. A structured questionnaire, validated by 2 international experts, addressed key prevention strategies with specific emphasis on AEE. Results: Infectious risk assessment was systematically performed, occasionally using risk scores (Prevention of Arrhythmia Device Infection Trial 12.1%; Charlson 3%). Annual infection incidence was most often tracked on a case-by-case basis (54.5%). Screening for Conclusion: This multicenter French survey highlights substantial gaps in physicians' knowledge and application of cardiac implantable electronic device infection prevention practices, despite the availability of clear European Society of Cardiology guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.